Soleus Private Equity Fund III, L.P.

13D and 13G Filings

13D/G filings
13G on 7 securities
Location
Greenwich, CT
CIK
0001955982
Form D filings
2 filings
All SEC filings
View on sec.gov
Issuer % of Class Filed
Nuvectis Pharma, Inc. 13G
NVCT · 67080T108
5.1% 8/6/2026
Event 8/4/2026
Prelude Therapeutics Inc 13G
PRLD · 74065P101
5.2% 7/8/2026
Event 4/21/2026
CalciMedica, Inc. 13G/A Amendment 4
CALC · 38942Q202
2.4% 5/8/2026
Event 3/31/2026
Aprea Therapeutics, Inc. 13G
APRE · 03836J102
10.0%
Checked 5% or less
4/1/2026
Event 4/1/2026
Invivyd, Inc. 13G/A Amendment 1
IVVD · 00534A102
2.8% 2/12/2026
Event 12/31/2025
CalciMedica, Inc. 13G/A Amendment 3
CALC · 38942Q202
7.5% 11/7/2025
Event 9/30/2025
Immunic, Inc. 13G/A Amendment 1
IMUX · 4525EP101
1.6% 11/7/2025
Event 9/30/2025
Invivyd, Inc. 13G
IVVD · 00534A102
5.1% 10/14/2025
Event 10/10/2025
Verastem, Inc. 13G/A Amendment 4
VSTM · 92337C203
1.8% 5/2/2025
Event 3/31/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.